2026 Financial Guidance 

In addition to providing guidance for GAAP revenue, Lilly provides guidance for certain non-GAAP measures.

The following table summarizes the company's updated full-year 2026 non-GAAP financial guidance, reflecting the strong revenue performance in Q1:



 

 

 		PriorUpdated


 

 

 

 

 
Revenue

 

 		$80 to $83 billion$82 to $85 billion


 

 

 

 

 
Performance Margin(1)(2)

 

 		46.0% to 47.5%47.0% to 48.5%


 

 

 

 

 
Tax Rate(1)(3)

 

 		18% to 19%Unchanged


 

 

 

 

 
Earnings per Share(1)(3)(4)

 

 		$33.50 to $35.00$35.50 to $37.00